Tissue scaffolds derived from forestomach extracellular matrix
The present invention pertains to the development of Extracellular Matrix (ECM) scaffolds derived from the forestomach of a ruminant. Such scaffolds are useful in many clinical and therapeutic applications, including wound repair, tissue regeneration, and breast reconstruction. In addition, the present invention features methods of isolating ECM scaffolds from mammalian organs, including but not limited to the ruminant forestomach. The invention further features laminated ECM scaffolds containing a polymer positioned between individual ECM sheets. The polymer may optionally contain bioactive molecules to enhance the functionality of the scaffold.
1. A tissue scaffold comprising a decellularized forestomach matrix of a ruminant mammal.
2. The tissue scaffold of claim 1 , wherein the forestomach matrix is derived from the rumen.
3. The tissue scaffold of claim 1 , further comprising decellularized tissue selected from the group consisting of epithelium, basement membrane, tunica muscularis, and combinations thereof.
4. The tissue scaffold of claim 1 , comprising a fibrillar protein selected from the group consisting of collagen I, collagen III, elastin, and combinations thereof.
5. The tissue scaffold of claim 1 , comprising a growth factor selected from the group consisting of Fibroblast Growth Factor (FGF-2), Transforming Growth Factor β1 (TGF-β1), TGF-β2, Vascular Endothelial Growth Factor (VEGF), and combinations thereof.
6. The tissue scaffold of claim 1 , comprising a glycosaminoglycan selected from the group consisting of hyaluronic acid, heparin sulfate, and combinations thereof.
7. The tissue scaffold of claim 1 , comprising an adhesive protein selected from the group consisting of fibronectin, laminin, collagen IV, and combinations thereof.
8. The tissue scaffold of claim 1 , wherein the scaffold is formatted as a single or laminated sheet.
9. The tissue scaffold of claim 8 , wherein the sheet has a width of at least 10 cm and a length of at least 10 cm.
10. The tissue scaffold of claim 8 , wherein the laminated sheets are secured together by stitches or sutures.
11. The tissue scaffold of claim 8 , wherein the sheet has an average burst strength of at least 80 N.
12. The tissue scaffold of claim 8 , wherein the laminated sheet comprises 2-12 layers of said scaffold.
13. The tissue scaffold of claim 12 , further comprising a polymer positioned between two or more layers of said laminated sheet.
14. The tissue scaffold of claim of claim 13 , wherein the polymer is selected from the group consisting of collagen, chitosan, alginate, polyvinyl alcohol, carboxymethyl cellulose, hydroxypropyl cellulose and combinations thereof.
15. The tissue scaffold of claim 13 , wherein the polymer further comprises a bioactive molecule.
16. The tissue scaffold of claim 15 , wherein the bioactive molecule is dispersed throughout a layer of the polymer.
17. The tissue scaffold of claim 15 , wherein the bioactive molecule is non-covalently dispersed in the polymer.
18. The tissue scaffold of claim 15 , wherein the bioactive molecule is a small molecule or peptide.
19. The tissue scaffold of claim 18 , wherein the bioactive molecule is selected from the group consisting of a growth factor, an anti-microbial, an analgesic, a hemostatic, a pro-angiogenic agent, an anti-angiogenic agent and combinations thereof.
20. The tissue scaffold of claim 19 , wherein the bioactive molecule is selected from the group consisting of Basic Fibroblast Growth Factor (FGF-2), Nerve Growth Factor (NGF), doxycycline, poly-L-lysine and combinations thereof.
21. The tissue scaffold of claim 1 , wherein the ruminant mammal is selected from the group consisting of Capra, Bos, Cervus and Ovis.
22. The tissue scaffold of claim 21 , wherein the ruminant mammal is Ovis aries.